All of these patients were hospitalized because of severe haematological disorders.

所有这些患者均因严重的血液病而入院治疗。

Objective: to discuss the clinical and haematological characteristics of sea-blue histiocytic syndrome (SBH).

目的：探讨海蓝组织细胞综合征(SBH)的临床及血液学特点。

Results: 80 % of the patients reached the haematological alleviation, 32 % of the patients occurred cytogenetical reaction.

结果：80 %患者达到血液学缓解，32 %患者产生细胞遗传学反应。

Objective To explore the expression of CD59 antigen from patients with haematological malignancies and its clinical significance.

目的探讨CD5 9抗原在血液系统恶性肿瘤患者红细胞及成熟粒细胞上的表达及意义。

The majority of people had received chemotherapy for a haematological malignancy or had undergone a hematopoietic stem cell transplant.

大多数人接受了恶性血液肿瘤化疗或造血干细胞移植。

Conclusion TATS has a differentiation inducing effect on untreated and recurrent APL, with haematological CR and cytogenetic CR achieved.

结论TATS对初治及复发APL有一定的诱导分化作用，单药TATS治疗初治及复发apl患者可达到血液学和细胞遗传学缓解。

These haematological difference of the treated groups were significant(P>0.05) or very significant(P>0.01) compared with the control group.

较高浓度试验组鲤鱼血液生理生化指标的变化与对照组间存在着显著（P＜0.05）或极显著（P＜0.01）的差异；

This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant (HSCT).

这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。

Now entering my fifth year of living with multiple myeloma, a haematological cancer, I reflect back on a roller-coaster ride of symptoms, treatments and side effects.

今年是我患上多发性骨髓瘤的第五个年头，这是一种血癌，我回顾了一下患上此病后的一系列突变的症状、治疗以及副作用。

Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.

入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。

Around one third of these cases occurred in patients whose immune systems were severely suppressed by haematological malignancy, aggressive chemotherapy for cancer, or post-transplant treatment.

其中约三分之一的患者因血液系统恶性肿瘤、癌症高强度化疗或移植后治疗而存在免疫系统严重低下的问题。